Barrie ON-based cannabis extractor
MediPharm Labs Corp. (
TSX.LABS) says it will supply the Brazilian medical marijuana market with its GMP-certified products to a local distributor,
the company reported Tuesday.
MediPharm announced that it will work with Rio de Janeiro-based XLR8 Brazil to supply the firm with several THC and CBD-related products through a two-year supply deal. XLR8 will be responsible for obtaining the necessary licensing from Brazil's health regulator to distribute MediPharm’s products, the company said.
Analysts expect Brazil's cannabis market to grow to as much as USD$12 billion by 2028.
New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.
For more of the latest info on Cannabis, check out the Cannabis Trending News hub on Stockhouse.